2015年11月Hepatology发表了加州大学伯克利分校Veronica教授团队的综述《丙型肝炎抗病毒药物耐药相关替换的研究进展》(Lontok E,et al.Hepatitis C virus drug resistance-associated substitutions:State of the art summary.Hepat...2015年11月Hepatology发表了加州大学伯克利分校Veronica教授团队的综述《丙型肝炎抗病毒药物耐药相关替换的研究进展》(Lontok E,et al.Hepatitis C virus drug resistance-associated substitutions:State of the art summary.Hepatology,2015,62:1623-1632)。展开更多
Three new nicotinamide adenine dinucleotide(NAD) analogs were synthesized,and their characteristics as cofactors for Escherichia coli malic enzyme(ME) and its double mutant ME L310R/Q401C were analyzed.Each pair of th...Three new nicotinamide adenine dinucleotide(NAD) analogs were synthesized,and their characteristics as cofactors for Escherichia coli malic enzyme(ME) and its double mutant ME L310R/Q401C were analyzed.Each pair of the NAD analog and the double mutant showed good orthogonality to the natural pair of NAD and ME in terms of catalyzing oxidative decarboxylation of L-malic acid.Results indicated that molecular interactions between redox enzyme and cofactor could be further explored to generate new bioorthogonal redox systems.展开更多
文摘2015年11月Hepatology发表了加州大学伯克利分校Veronica教授团队的综述《丙型肝炎抗病毒药物耐药相关替换的研究进展》(Lontok E,et al.Hepatitis C virus drug resistance-associated substitutions:State of the art summary.Hepatology,2015,62:1623-1632)。
基金supported by the National Basic Research Program of China (2012CB721103)
the National Natural Science Foundation of China (21102143)
文摘Three new nicotinamide adenine dinucleotide(NAD) analogs were synthesized,and their characteristics as cofactors for Escherichia coli malic enzyme(ME) and its double mutant ME L310R/Q401C were analyzed.Each pair of the NAD analog and the double mutant showed good orthogonality to the natural pair of NAD and ME in terms of catalyzing oxidative decarboxylation of L-malic acid.Results indicated that molecular interactions between redox enzyme and cofactor could be further explored to generate new bioorthogonal redox systems.